Recent studies are deepening concerns over the increasing frequency of MRI procedures using MRI contrast agents, and their effect on patients with kidney disease.

New federal figures suggest that hospitals across the county are administering too many imaging procedures. In South Florida, 24 percent of patients who received a chest CT scan at Columbia Hospital in West Palm Beach actually received two. One scan was administered with a contrasting agent, and one without.

While contrasting agents in CT scan have not been in the news lately, those used in MRI scans are a growing concern. Gadolinium-based contrasting agents have been linked to nephrogenic system fibrosis in patients with compromised kidneys. Patients with kidney failure may not be in a position to quickly and efficiently rid their systems of the gadolinium, without the aid of dialysis.

If you have developed NSF because of gadolinium-based agents, you may be eligible for compensation. Contact a gadolinium attorney of Williams Kherkher by calling 800-761-3187.